Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas
暂无分享,去创建一个
P. Chanson | A. Tabarin | F. Keleştimur | M. Fleseriu | M. Bidlingmaier | I. Shimon | M. Christ-Crain | M. Gadelha | Yutaka Takahashi | C. Scaroni | M. Gurnell | C. Boguszewski | R. Ross | A. Lacroix | N. Tritos | Y. Greenman | N. Karavitaki | Artak Labadzhyan | R. Salvatori | A. McCormack | G. Raverot | N. Biermasz | A. Drincic | S. Neggers | G. Vila | S. Tsagarakis | R. Pivonello | S. Petersenn | S. Frara | L. Katznelson | K. Ho | Susmeeta T. Sharma | A. Ioachimescu | M. Gordon | J. Carmichael | Ismat Shafiq | P. Fazeli | I. Bancos | D. Niculescu | E. Valassi | Yuval Eisenberg | H. Fukuoka | F. Guarda | F. Langlois | D. Lim | Maria M. Pineyro | M. Ilie | Jessica Brzana | S. Mallea-Gil | Irina Martin Nienke Cesar Luiz Jessica John Philippe And Bancos Bidlingmaier Biermasz Boguszewski Br | Luma Ghalib | Miguel Hinojosa-Amaya | Maggie Wierman | I. Shafiq
[1] M. Shiroishi,et al. Silent Corticotroph Pituitary Adenomas: Clinical Characteristics, Long-Term Outcomes, and Management of Disease Recurrence , 2021, Journal of Neurological Surgery Part B: Skull Base.
[2] S. Samson,et al. A Pituitary Society update to acromegaly management guidelines , 2020, Pituitary.
[3] M. Maksymowicz,et al. Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery , 2020, Frontiers in Endocrinology.
[4] S. Melmed. Pituitary-Tumor Endocrinopathies. , 2020, The New England journal of medicine.
[5] S. Petersenn. Biochemical diagnosis in prolactinomas: some caveats , 2019, Pituitary.
[6] A. Barkan,et al. Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations , 2019, Clinical diabetes and endocrinology.
[7] V. Hach-Wunderle,et al. Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy. , 2018, VASA. Zeitschrift fur Gefasskrankheiten.
[8] M. Mohajeri-Tehrani,et al. Pituitary Macroprolactinoma with Mildly Elevated Serum Prolactin: Hook Effect , 2018, Advanced journal of emergency medicine.
[9] P. Chanson,et al. Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. , 2018, European journal of endocrinology.
[10] C. Yedinak,et al. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review , 2018, Pituitary.
[11] M. Fleseriu,et al. Silent somatotroph pituitary adenomas: an update , 2018, Pituitary.
[12] P. Chanson,et al. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement , 2017, Pituitary.
[13] M. Molitch. Diagnosis and Treatment of Pituitary Adenomas: A Review , 2017, JAMA.
[14] M. Murad,et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.
[15] N. Oyesiku,et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas. , 2016, Neurosurgery.
[16] N. Oyesiku,et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pretreatment Endocrine Evaluation of Patients With Nonfunctioning Pituitary Adenomas. , 2016, Neurosurgery.
[17] A. Tabarin,et al. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. , 2015, The Journal of clinical endocrinology and metabolism.
[18] A. Klibanski,et al. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. , 2015, The Journal of clinical endocrinology and metabolism.
[19] P. Chanson,et al. Management of clinically non-functioning pituitary adenoma. , 2015, Annales d'endocrinologie.
[20] A. Hoffman,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: MANAGEMENT OF ACROMEGALY PATIENTS: WHAT IS THE ROLE OF PRE-OPERATIVE MEDICAL THERAPY? , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[21] I. Chiodini,et al. Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma. , 2015, European journal of endocrinology.
[22] A. Tabarin,et al. Accuracy of repeated measurements of late‐night salivary cortisol to screen for early‐stage recurrence of Cushing's disease following pituitary surgery , 2015, Clinical endocrinology.
[23] E. Laws,et al. Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.
[24] Eun Jig Lee,et al. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. , 2012, Neurosurgery.
[25] O. Sibony,et al. Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review , 2011, PloS one.
[26] V. Montori,et al. Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline , 2011, The Journal of clinical endocrinology and metabolism.
[27] Victor M Montori,et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[28] A. Klibanski,et al. Clinical features of nonpituitary sellar lesions in a large surgical series , 2010, Clinical endocrinology.
[29] L. Nieman,et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. , 2008, The Journal of clinical endocrinology and metabolism.
[30] V. Montori,et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[31] T. Sano,et al. A STUDY OF THE CORRELATION BETWEEN MORPHOLOGICAL FINDINGS AND BIOLOGICAL ACTIVITIES IN CLINICALLY NONFUNCTIONING PITUITARY ADENOMAS , 2007, Neurosurgery.
[32] P. Cappabianca,et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas , 2006, Clinical endocrinology.
[33] M. Fleseriu,et al. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of ‘hook effect’ , 2006, Journal of Neuro-Oncology.
[34] T. Lenarz,et al. Falsely Low Serum Prolactin in Two Cases of Invasive Macroprolactinoma , 2004, Pituitary.
[35] F. Hasson,et al. A critical review of the Delphi technique as a research methodology for nursing. , 2001, International journal of nursing studies.
[36] F. Hasson,et al. Research guidelines for the Delphi survey technique. , 2000, Journal of advanced nursing.
[37] P. Freda,et al. Differential diagnosis of sellar masses. , 1999, Endocrinology and metabolism clinics of North America.